Seven children with a primary myelodysplastic syndrome were seen at our center over a 9-year period. Two presented with refractory anemia, three with refractory anemia with excess of blasts, and two with refractory anemia with excess of blasts in transformation. All children received supportive therapy, including blood transfusions in five of them. Three patients developed acute myeloid leukemia and were treated with intensive chemotherapy, followed by allogeneic or autologous marrow transplantation in the two responders. All three died of either infection or progressive disease. The other four patients are still alive a median of 71 months (range 38-130) after diagnosis. These results confirm the difficulties in managing patients with myel...
Myelodysplastic syndrome (MDS) constitutes 1-16% of hematological malignancies in the childhood peri...
Myelodysplastic syndrome (MDS) represent very heterogenous group of clonal stem cell bone marrow dis...
The myelodysplastic syndrome (MDS) is a rare, clonal disorder of pluripotent stem cells in children ...
Seven children with a primary myelodysplastic syndrome were seen at our center over a 9-year period....
Seven children with a primary myelodysplastic syndrome were seen at our center over a 9-year period....
Myelodysplastic syndromes (MDS) are clonal disorders of the multipotent hematopoietic stem cell char...
Primary myelodysplasia (MDS) without an increased number of blasts is a rare finding in childhood. W...
Primary myelodysplasia (MDS) without an increased number of blasts is a rare finding in childhood. W...
Myelodysplastic syndrome (MDS) constitutes 1-16% percent of haematological malignancies in childhood...
Myelodysplastic syndromes (MDS) are clonal disorders of the multipotent hematopoietic stem cell char...
Fourteen pediatric cases of myelodysplastic syndrome according to French-American-British Cooperativ...
Pediatric myelodysplastic syndromes (MDSs) are a heterogeneous group of clonal disorders with an ann...
We reviewed the clinical features, treatment, and outcome of 100 children with myelodysplastic syndr...
Fifty three (45 males, 8 females) patients with primary meylodysplastic syndrome were seen between J...
Forty-four cases of myelodysplasia in children were studied. A third of the cases were unclassifiabl...
Myelodysplastic syndrome (MDS) constitutes 1-16% of hematological malignancies in the childhood peri...
Myelodysplastic syndrome (MDS) represent very heterogenous group of clonal stem cell bone marrow dis...
The myelodysplastic syndrome (MDS) is a rare, clonal disorder of pluripotent stem cells in children ...
Seven children with a primary myelodysplastic syndrome were seen at our center over a 9-year period....
Seven children with a primary myelodysplastic syndrome were seen at our center over a 9-year period....
Myelodysplastic syndromes (MDS) are clonal disorders of the multipotent hematopoietic stem cell char...
Primary myelodysplasia (MDS) without an increased number of blasts is a rare finding in childhood. W...
Primary myelodysplasia (MDS) without an increased number of blasts is a rare finding in childhood. W...
Myelodysplastic syndrome (MDS) constitutes 1-16% percent of haematological malignancies in childhood...
Myelodysplastic syndromes (MDS) are clonal disorders of the multipotent hematopoietic stem cell char...
Fourteen pediatric cases of myelodysplastic syndrome according to French-American-British Cooperativ...
Pediatric myelodysplastic syndromes (MDSs) are a heterogeneous group of clonal disorders with an ann...
We reviewed the clinical features, treatment, and outcome of 100 children with myelodysplastic syndr...
Fifty three (45 males, 8 females) patients with primary meylodysplastic syndrome were seen between J...
Forty-four cases of myelodysplasia in children were studied. A third of the cases were unclassifiabl...
Myelodysplastic syndrome (MDS) constitutes 1-16% of hematological malignancies in the childhood peri...
Myelodysplastic syndrome (MDS) represent very heterogenous group of clonal stem cell bone marrow dis...
The myelodysplastic syndrome (MDS) is a rare, clonal disorder of pluripotent stem cells in children ...